Pharmasim ophthalmology case study

1
Case Study: Simulation Modelling in Ophthalmology Introduction: Our client wanted to introduce a treatment for long-term conditions with a different posology to the current standard of treatment that would have a significant (but as yet unquantified) impact on services at a local level. The client wanted to find a way to engage Trusts and have conversations based on the most up-to-date real world evidence available both on the value proposition and case for change. Challenge: To find a way to engage ophthalmology departments, highlight the key issues, collaborate on resource implications and plan how to introduce change when the impact is multi-factorial with potentially hidden consequences over multiple years Actions: To develop a simulation model that maps ophthalmology department workflow with enough flexibility to be able to encompass any Trust in the UK that contains all of the available validated real world data and that takes the interplay of all of the relevant factors into account Methodology: We engaged frontline NHS clinicians and staff at ophthalmology departments of various sizes and grades, gathered requirements, collected data and confirmed the pathway options. This was signed off before development of the model. We built an interim model that was used to gain feedback from stakeholders across the country before building a final model that was rolled out for use nationwide in around 3 months. Result: The model supported the client to conduct intense engagement with UK ophthalmology departments enabling successful market access. It was used to convince multiple NHS Trusts of the need for a rethink and also supported a range of Trusts to explore what that change could mean for them. For more information on PharmaSim visit www.healthiq.co.uk or contact us on [email protected] / 020 3176 6130

description

 

Transcript of Pharmasim ophthalmology case study

Page 1: Pharmasim ophthalmology case study

 

 

Case Study: Simulation Modell ing in Ophthalmology Introduction: Our client wanted to introduce a treatment for long-term conditions with a different posology to the current standard of treatment that would have a significant (but as yet unquantified) impact on services at a local level. The client wanted to find a way to engage Trusts and have conversations based on the most up-to-date real world evidence available both on the value proposition and case for change. Challenge: To find a way to engage ophthalmology departments, highlight the key issues, collaborate on resource implications and plan how to introduce change when the impact is multi-factorial with potentially hidden consequences over multiple years Actions: To develop a simulation model that maps ophthalmology department workflow with enough flexibility to be able to encompass any Trust in the UK that contains all of the available validated real world data and that takes the interplay of all of the relevant factors into account Methodology: We engaged frontline NHS clinicians and staff at ophthalmology departments of various sizes and grades, gathered requirements, collected data and confirmed the pathway options. This was signed off before development of the model. We built an interim model that was used to gain feedback from stakeholders across the country before building a final model that was rolled out for use nationwide in around 3 months. Result: The model supported the client to conduct intense engagement with UK ophthalmology departments enabling successful market access. It was used to convince multiple NHS Trusts of the need for a rethink and also supported a range of Trusts to explore what that change could mean for them. For more information on PharmaSim visit www.healthiq.co.uk or contact us on [email protected] / 020 3176 6130